Dr. Laurie Griffin is a Maternal-Fetal Medicine doctor who believes that pregnancy is an important time to address both the short- and long-term health of pregnant patients and their families. She treats patients with chronic conditions, twin and higher-order multiple pregnancies, and pregnancies complicated by fetal anomalies or placental abnormalities. She is also a physician in the Utah Pregnancy after Loss Program (UPAL), where she provides physical and emotional support to help families navigate the added complexities of pregnancy and the postpartum period that may exist after fetal or neonatal loss.

Dr. Griffin is physician researcher. She received her medical degree and PhD in Cellular and Molecular Biology from the University of Michigan. She completed her residency in Obstetrics and Gynecology and fellowship in Maternal-Fetal Medicine at Women & Infants Hospital/Brown University. She has NIH supported research on the treatment of hypertension in pregnancy and additional projects focused on vaccination in pregnancy, stillbirth, and partner health.

She is currently accepting new patients for prenatal care and perinatal counseling at Sugar House Health Center and the Ambulatory Care Complex at the University of Utah Hospital.

When not caring for patients, Dr. Griffin enjoys spending time in the mountains with her family.

Specialties

Board Certification

American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)

Board Certification and Academic Information

Academic Departments	Obstetrics & Gynecology -Assistant Professor
Academic Divisions	Maternal Fetal Medicine
Board Certification	American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)

Education history

Undergraduate	Major: Molecular Biology & Biochemistry; Minor: Chinese - Middlebury College	B.A.
Professional Medical	Medical Scientist Training Program - University of Michigan Medical School	M.D.
Doctoral Training	Cellular and Molecular Biology - University of Michigan Rackham Graduate School	Ph.D.
Residency	Obstetrics and Gynecology - Women & Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University	Resident
Fellowship	Maternal-Fetal Medicine - Women & Infants Hospital of Rhode Island, Warren Alpert Medical School of Brown University	Fellow

Selected Publications

Journal Article

Griffin LB, Passarelli N, Whelan A, Russo M, Zitek E, Hardy E, Clark MA, Lewkowitz A (2025). Assessment of Obstetric Providers' Practice Surrounding Vaccine Counseling and Administration for Non-Birthing Partners. Rhode Island medical journal (2013), 108(9), 36-41.
Griffin LB, Polnaszek BE, Shin J, Clark MA, Lewkowitz AK, Amanullah S, Gjelsvik (2025). Parental status and gender are associated with differences in Tdap vaccination rates among United States adults. Vaccine, 52, 126901.
Polnaszek BE, Griffin LB, Whelan AR, Soehl J, Clark MA, Lewkowitz AK, Hamel (2024). Obstetric Emergency Simulation: A Pre/Post Survey Analysis of High-Fidelity Teamwork Among Emergency Department Physicians. Rhode Island medical journal (2013), 107(7), 36-38.
Griffin LB, Sinkey R, Tita A, Rouse D (2024). Nonsevere hypertensive disorders of pregnancy and oral antihypertensive medications: an argument against use. American journal of obstetrics & gynecology MFM, 101560.
Whelan AR, Griffin LB, Russo ML, Ayala NK, Miller ES, Clark M (2024). Posttraumatic Stress Symptoms among Obstetricians with Personal Experience of Birth Trauma. American journal of perinatology,
Polnaszek BE, Griffin LB, Amanullah S, Tuuli MG, Lewkowitz AK, Gjelsvik (2024). Parental Health and Flourishing Among Young US Children. JAMA network open, 7(10), e2443975.
Siegel MR, James K, Bromley B, Koelper NC, Chasen ST, Griffin L, Roman AS, Limaye M, Ranzini A, Clifford C, Biggio JR, Subramaniam A, Seasely AR, Page JM, Nicholas SS, Idler J, Rao R, Shree R, McLennan G, Dugoff L, Twin cfDNA Study Consortiu (2024). First-Trimester Cell-Free DNA Fetal Fraction and Birth Weight in Twin Pregnancies. American journal of perinatology,
Griffin LB, McCarthy M, Russo M (2023). Navigation of Prenatal Care With Sex Discordance Between Cell-free DNA and Ultrasound Findings. Clinical obstetrics and gynecology, 66(3), 616-623.
Murphy LM, Whelan AR, Griffin LB, Hamel M (2023). A pilot randomized control trial of topical capsaicin as adjunctive therapy for nausea and vomiting of pregnancy. American journal of obstetrics & gynecology MFM, 5(7), 100997.
Lewkowitz AK, Griffin LB, Miller ES, Howard E (2022). A Missed Opportunity? How Prenatal Care, Birth Hospitalization, and Digital Health Could Increase Nonbirthing Partners' Access to Recommended Medical and Mental Healthcare. The Journal of perinatal & neonatal nursing, 36(4), 330-334.
Griffin LB, Ding JJ, Has P, Ayala N, Kole-White M (2022). Lactation Consultation by an International Board Certified Lactation Consultant Improves Breastfeeding Rates for Mothers With Gestational Diabetes Mellitus. Journal of human lactation, 38(1), 141-147.
Kole-White MB, Griffin L, Ding JJ, Ayala NK, Has P, Werner E (2021). Breastfeeding Success Among Women with Gestational Diabetes Managed by Diet Only Compared with Those Requiring Medications. Breastfeeding medicine, 16(5), 419-423.
Griffin LB, López JD, Ranney ML, Macones GA, Cahill AG, Lewkowitz A (2021). Effect of Novel Breastfeeding Smartphone Applications on Breastfeeding Rates. Breastfeeding medicine, 16(8), 614-623.
Morelli KH, Griffin LB, Pyne NK, Wallace LM, Fowler AM, Oprescu SN, Takase R, Wei N, Meyer-Schuman R, Mellacheruvu D, Kitzman JO, Kocen SG, Hines TJ, Spaulding EL, Lupski JR, Nesvizhskii A, Mancias P, Butler IJ, Yang XL, Hou YM, Antonellis A, Harper SQ, Burgess R (2019). Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse models. The Journal of clinical investigation, 129(12), 5568-5583.
Williams KB, Brigatti KW, Puffenberger EG, Gonzaga-Jauregui C, Griffin LB, Martinez ED, Wenger OK, Yoder MA, Kandula VVR, Fox MD, Demczko MM, Poskitt L, Furuya KN, Reid JG, Overton JD, Baras A, Miles L, Radhakrishnan K, Carson VJ, Antonellis A, Jinks RN, Strauss K (2019). Homozygosity for a mutation affecting the catalytic domain of tyrosyl-tRNA synthetase (YARS) causes multisystem disease. Human molecular genetics, 28(4), 525-538.
Antonellis A, Oprescu SN, Griffin LB, Heider A, Amalfitano A, Innis J (2018). Compound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease. Human mutation, 39(6), 834-840.
Abbott JA, Meyer-Schuman R, Lupo V, Feely S, Mademan I, Oprescu SN, Griffin LB, Alberti MA, Casasnovas C, Aharoni S, Basel-Vanagaite L, Züchner S, De Jonghe P, Baets J, Shy ME, Espinós C, Demeler B, Antonellis A, Francklyn (2018). Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy. Human mutation, 39(3), 415-432.
Oprescu SN, Griffin LB, Beg AA, Antonellis (2017). Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations. Methods (San Diego, Calif.), 113, 139-151.
Griffin LB, Farley FA, Antonellis A, Keegan C (2016). A novel FGD1 mutation in a family with Aarskog-Scott syndrome and predominant features of congenital joint contractures. Cold Spring Harbor molecular case studies, 2(4), a000943.
Malissovas N, Griffin LB, Antonellis A, Beis (2016). Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease. Human molecular genetics, 25(8), 1528-42.
Gonzaga-Jauregui C, Harel T, Gambin T, Kousi M, Griffin LB, Francescatto L, Ozes B, Karaca E, Jhangiani SN, Bainbridge MN, Lawson KS, Pehlivan D, Okamoto Y, Withers M, Mancias P, Slavotinek A, Reitnauer PJ, Goksungur MT, Shy M, Crawford TO, Koenig M, Willer J, Flores BN, Pediaditrakis I, Us O, Wiszniewski W, Parman Y, Antonellis A, Muzny DM, Baylor-Hopkins Center for Mendelian Genomics, Katsanis N, Battaloglu E, Boerwinkle E, Gibbs RA, Lupski J (2015). Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy. Cell reports, 12(7), 1169-83.
Abrams AJ, Hufnagel RB, Rebelo A, Zanna C, Patel N, Gonzalez MA, Campeanu IJ, Griffin LB, Groenewald S, Strickland AV, Tao F, Speziani F, Abreu L, Schüle R, Caporali L, La Morgia C, Maresca A, Liguori R, Lodi R, Ahmed ZM, Sund KL, Wang X, Krueger LA, Peng Y, Prada CE, Prows CA, Schorry EK, Antonellis A, Zimmerman HH, Abdul-Rahman OA, Yang Y, Downes SM, Prince J, Fontanesi F, Barrientos A, Németh AH, Carelli V, Huang T, Zuchner S, Dallman J (2015). Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder. Nature genetics, 47(8), 926-32.
Safka Brozkova D, Deconinck T, Griffin LB, Ferbert A, Haberlova J, Mazanec R, Lassuthova P, Roth C, Pilunthanakul T, Rautenstrauss B, Janecke AR, Zavadakova P, Chrast R, Rivolta C, Zuchner S, Antonellis A, Beg AA, De Jonghe P, Senderek J, Seeman P, Baets (2015). Loss of function mutations in HARS cause a spectrum of inherited peripheral neuropathies. Brain, 138(Pt 8), 2161-72.
Motley WW, Griffin LB, Mademan I, Baets J, De Vriendt E, De Jonghe P, Antonellis A, Jordanova A, Scherer S (2015). A novel AARS mutation in a family with dominant myeloneuropathy. Neurology, 84(20), 2040-7.
Simons C, Griffin LB, Helman G, Golas G, Pizzino A, Bloom M, Murphy JL, Crawford J, Evans SH, Topper S, Whitehead MT, Schreiber JM, Chapman KA, Tifft C, Lu KB, Gamper H, Shigematsu M, Taft RJ, Antonellis A, Hou YM, Vanderver (2015). Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect. American journal of human genetics, 96(4), 675-81.
Griffin LB, Sakaguchi R, McGuigan D, Gonzalez MA, Searby C, Züchner S, Hou YM, Antonellis (2014). Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Human mutation, 35(11), 1363-71.
Schimenti KJ, Feuer SK, Griffin LB, Graham NR, Bovet CA, Hartford S, Pendola J, Lessard C, Schimenti JC, Ward J (2013). AKAP9 is essential for spermatogenesis and sertoli cell maturation in mice. Genetics, 194(2), 447-57.
Grohar PJ, Woldemichael GM, Griffin LB, Mendoza A, Chen QR, Yeung C, Currier DG, Davis S, Khanna C, Khan J, McMahon JB, Helman L (2011). Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening. Journal of the National Cancer Institute, 103(12), 962-78.
Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, Khan J, Helman L (2011). Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Neoplasia (New York, N.Y.), 13(2), 145-53.
Ward JO, Reinholdt LG, Motley WW, Niswander LM, Deacon DC, Griffin LB, Langlais KK, Backus VL, Schimenti KJ, O'Brien MJ, Eppig JJ, Schimenti J (2007). Mutation in mouse hei10, an e3 ubiquitin ligase, disrupts meiotic crossing over. PLoS genetics, 3(8), e139.

Editorial

Boudova S, Griffin L, Martinez-King C, Soehl J, Watkins V, Yang (2024). Increasing dialogue surrounding controversies in antepartum management among trainees. American journal of obstetrics & gynecology MFM, 7(1), 101558.

Letter

Griffin LB, Whelan J, Passarelli N, Zitek E, Hardy E, Clark MA, Lewkowitz A (2025). Impact of prenatal vaccination counseling on nonbirthing partners' vaccination rates. American journal of obstetrics & gynecology MFM, 7(7), 101635.

News & Podcasts

News

Is Caffeine Safe During Pregnancy?